Skip to main content
Equibles

Dr. Christine Borowski

Board Member

Yarrow Bioscience, Inc. (YARW)

Equibles does not estimate personal net worth.

Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get YARW alerts

About Dr. Christine Borowski

Dr. Christine Borowski is recorded as Board Member at Yarrow Bioscience, Inc. (YARW) since January 1, 2024. Yarrow Bioscience, Inc. reported in an 8-K filed August 14, 2025 that Dr. Christine Borowski resigned as member of the Board, effective August 11, 2025. Yarrow Bioscience, Inc. reported in an 8-K filed January 3, 2024 that Dr. Christine Borowski was appointed Class II director, effective January 1, 2024. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.

“On August 11, 2025, Christine Borowski, Ph.D. provided notice to the board of directors (the "Board") of her resignation as member of the Board and as a member of the Nominating and Corporate Governance Committee effective immediately.”
Yarrow Bioscience, Inc. Form 8-K, filed August 14, 2025 · Read the filing
“On December 29, 2023, the Board appointed Dr. Christine Borowski to serve as a Class II director of the Company, effective as of January 1, 2024, for a term continuing to the Company's 2026 annual meeting of stockholders and until her successor is appointed.”
Yarrow Bioscience, Inc. Form 8-K, filed January 3, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Yarrow Bioscience, Inc.

Recent activity